The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMC 3471664)

Published in J Ment Health Policy Econ on September 01, 2012

Authors

Seo Hyon Baik1, Bruce L Rollman, Charles F Reynolds, Judith R Lave, Kenneth J Smith, Yuting Zhang

Author Affiliations

1: Department of Health Policy and Management, University of Pittsburgh, Pittsburgh, PA 15261, USA.

Articles cited by this

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

A strategy to reduce cardiovascular disease by more than 80%. BMJ (2003) 19.05

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry (1993) 9.09

Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31

The effect of Medicare Part D on drug and medical spending. N Engl J Med (2009) 5.55

Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol (2006) 4.97

Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96

Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol (2001) 2.86

The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry (1998) 2.81

Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J (2007) 2.12

The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood) (2009) 2.02

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J (2008) 1.97

The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) (2009) 1.95

Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry (1998) 1.95

Depression-related costs in heart failure care. Arch Intern Med (2002) 1.91

Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail (2008) 1.78

Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res (2009) 1.66

Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care (2008) 1.44

The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care (2010) 1.43

Post-myocardial infarction depression. Evid Rep Technol Assess (Summ) (2005) 1.40

Medicare Part D coverage gap and diabetes beneficiaries. Am J Manag Care (2009) 1.40

Part D coverage gap and adherence to diabetes medications. Am J Manag Care (2010) 1.33

Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Ann Intern Med (2012) 1.29

Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study. J Am Geriatr Soc (2010) 1.14

Psychological predictors of prognosis in chronic heart failure. J Card Fail (2008) 1.13

Mental disorders, quality of care, and outcomes among older patients hospitalized with heart failure: an analysis of the national heart failure project. Arch Gen Psychiatry (2008) 0.97

Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. Arch Gen Psychiatry (2012) 0.96

Articles by these authors

Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA (2004) 8.83

The effect of Medicare Part D on drug and medical spending. N Engl J Med (2009) 5.55

Treatment of complicated grief: a randomized controlled trial. JAMA (2005) 5.15

Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses. Ann Intern Med (2009) 4.61

Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med (2003) 4.30

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA (2003) 4.22

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol (2002) 4.18

Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA (2009) 4.06

Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med (2011) 3.73

Recruiting and retaining future generations of physician scientists in mental health. Arch Gen Psychiatry (2002) 3.69

Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med (2006) 3.27

The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17

Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med (2005) 3.13

Confronting depression and suicide in physicians: a consensus statement. JAMA (2003) 3.06

The impact of national health care reform on adults with severe mental disorders. Am J Psychiatry (2011) 3.06

The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06

Preventing depression: a global priority. JAMA (2012) 2.92

Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70

Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA (2009) 2.60

Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry (2009) 2.56

Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med (2010) 2.50

Potential savings from greater use of $4 generic drugs. Arch Intern Med (2011) 2.48

Retail clinics, primary care physicians, and emergency departments: a comparison of patients' visits. Health Aff (Millwood) (2008) 2.44

Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med (2009) 2.40

Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med (2007) 2.39

Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35

Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30

Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29

Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med (2006) 2.27

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry (2013) 2.23

Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med (2006) 2.22

The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study. J Am Geriatr Soc (2005) 2.20

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis (2007) 2.19

Health reform and the scope of benefits for mental health and substance use disorder services. Psychiatr Serv (2010) 2.18

A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatr Blood Cancer (2007) 2.15

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res (2003) 2.14

Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making (2005) 2.10

A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res (2006) 2.08

Depression, antidepressants, and bone health in older adults: a systematic review. J Am Geriatr Soc (2014) 2.08

Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry (2005) 2.04

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol (2010) 2.03

The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood) (2009) 2.02

Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain (2007) 1.94

Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care. BMJ (2013) 1.91

Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol (2003) 1.88

Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol (2014) 1.85

Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression. J Am Geriatr Soc (2007) 1.85

Using simulation to isolate physician variation in intensive care unit admission decision making for critically ill elders with end-stage cancer: a pilot feasibility study. Crit Care Med (2008) 1.81

Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry (2006) 1.77

Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry (2002) 1.77

Persistence of racial disparities in advance care plan documents among nursing home residents. J Am Geriatr Soc (2002) 1.76

Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry (2005) 1.76

The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med (2006) 1.75

Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75

Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol (2002) 1.74

Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry (2006) 1.73

Procedural experience with out-of-hospital endotracheal intubation. Crit Care Med (2005) 1.72

Translating evidence-based depression management services to community-based primary care practices. Milbank Q (2004) 1.72

Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis. Cell Cycle (2012) 1.71

Comparison of symptom management strategies for pain, erectile dysfunction, and depression in patients receiving chronic hemodialysis: a cluster randomized effectiveness trial. Clin J Am Soc Nephrol (2012) 1.71

Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry (2002) 1.70

Neurological deficits caused by tissue hypoxia in neuroinflammatory disease. Ann Neurol (2013) 1.70

Outcomes after out-of-hospital endotracheal intubation errors. Resuscitation (2008) 1.69

Effect of rehabilitation site on functional recovery after hip fracture. Arch Phys Med Rehabil (2005) 1.69

Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol (2004) 1.68

Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry (2007) 1.68

Mental health treatment seeking among older adults with depression: the impact of stigma and race. Am J Geriatr Psychiatry (2010) 1.67

National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. Ann Intern Med (2010) 1.67

Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry (2007) 1.67

Economics of influenza vaccine administration timing for children. Am J Manag Care (2010) 1.65

A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry (2005) 1.65

Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc (2014) 1.65

Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry (2012) 1.62

Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients. Infect Control Hosp Epidemiol (2008) 1.61

Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry (2003) 1.60

Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain (2004) 1.60

Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry (2007) 1.60

The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry (2007) 1.59

Development and validation of hospital "end-of-life" treatment intensity measures. Med Care (2009) 1.58

Alcohol and drug use and related disorders: An underrecognized health issue among adolescents and young adults attending sexually transmitted disease clinics. Sex Transm Dis (2006) 1.57

Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial. Am J Med (2003) 1.57

Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med (2002) 1.57

Emerging models of depression care: multi-level ('6 P') strategies. Int J Methods Psychiatr Res (2003) 1.55

Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54

Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. Brain (2013) 1.53

Programs for developing the pipeline of early-career geriatric mental health researchers: outcomes and implications for other fields. Acad Med (2010) 1.52

Physician office visits of adults for anxiety disorders in the United States, 1985-1998. J Gen Intern Med (2002) 1.52

Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture. Int J Geriatr Psychiatry (2004) 1.51

The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry (2013) 1.51

Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc (2007) 1.50

Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain (2002) 1.50

Bereavement, complicated grief, and DSM, part 1: depression. J Clin Psychiatry (2010) 1.49

Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry (2005) 1.49

A developmental model for enhancing research training during psychiatry residency. Acad Psychiatry (2006) 1.48

Empirically derived decision trees for the treatment of late-life depression. Am J Psychiatry (2008) 1.48

Patterns of mild cognitive impairment after treatment of depression in the elderly. Am J Geriatr Psychiatry (2009) 1.48

Potential value of regionalized intensive care for mechanically ventilated medical patients. Am J Respir Crit Care Med (2007) 1.47

Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena. Am J Geriatr Psychiatry (2009) 1.47

The relationship of medical comorbidity and depression in older, primary care patients. Psychosomatics (2006) 1.47